- Country: Cyprus
Latest coverage
- Country: United States
Vaxcyte jumps on phase 3 data for pneumonia vaccine VAX-31
- Country: Cyprus
Vaxcyte’s VAX-31 vaccine meets primary endpoints in phase 3 trial
- Country: United States
Vaxcyte to Present Topline Phase 3 Data for VAX-31 Vaccine
VAX-31 met noninferiority on all 28 shared serotypes and superiority on 3 unique ones in Oct. 5 OPUS-1 data; Pickering called it a new class benchmark.